| INTRODUCTION
Placental dysfunction is cited as a cause of death in up to 65% of stillbirths. 1, 2 Until recently, investigations of the origins of placental dysfunction have generally concentrated on the implications of failure of spiral artery remodeling as seen in early onset pre-eclampsia and fetal growth restriction (FGR). 3 However, interest has grown in the consequences of placental inflammation and its contribution as a cause of stillbirth and FGR. Infectious agents such as cytomegalovirus or toxoplasmosis can lead to placental inflammation, although such cases are usually in the minority. 4 More frequently, placental inflammation occurs in the absence of infection. 5 Villitis of unknown etiology (VUE) is one such inflammatory condition of the villous tissue. As its name suggests, the origin of VUE is unknown, but it is not attributable to infectious agents.
Villitis of unknown etiology occurs in approximately 15% of term placentas, with a higher incidence in FGR. 6 Increased severity of inflammation has been linked to stillbirth, 4 and it has been reported that VUE may recur in subsequent pregnancies. 7 VUE is characterized by infiltration of the placental villous stroma by maternal CD4 and CD8
T cells 8, 9 and expansion of the placental macrophage (Hofbauer cell) population [9] [10] [11] [12] [13] The mechanisms by which this inflammatory infiltrate negatively affects placental function are unknown. We recently demonstrated altered cytokine protein levels in VUE lesions, including reduced interleukin (IL)-4 and elevated IL-2 and -12, indicating a localized pro-inflammatory environment in this placenta, which could disrupt normal placental viability and function. 10 We hypothesized that the presence of maternal CD4 and CD8
T cells and/or their related cytokines in the villous stroma damages trophoblast, the key functional cell layer, leading to impaired placental function. As VUE is diagnosed on histological examination of the placenta after delivery, it cannot be detected before birth. This limits the ability to assess the effects of VUE on placental function using a traditional case-control or cohort study design. In the current study, we developed a novel in vitro model of VUE, whereby maternal T cells (CD4 and CD8) were co-incubated with, and infiltrated, villous tissue explants from matched placentas to assess the impact on placental function. We also utilized an established placental explant model to perturb specific cytokine levels, to reproduce the cytokine environment found in VUE in vivo. 10, [14] [15] [16] [17] [18] In both cases, a range of established placental analyses were used to assess the impact on trophoblast viability and placental function including cell turnover, nutrient transport, and endocrine function. 
| MATERIALS AND METHODS

| Sample collection
| Explant culture with cytokines
Full thickness villous biopsies of ~1 cm 3 were randomly sampled from four different areas of placenta and dissected into 4-5 mm 2 fragments.
An established method of placental explant culture that has been extensively utilized to assess placental viability and function was employed. 15, 18, 19 Explants were cultured for 4 days in CMRL-1066 culture medium (Gibco, Paisley, UK) supplemented with 5% heat-inactivated fetal bovine serum (FBS), 100 IU mL −1 penicillin, 100 μg mL −1 streptomycin, 1 μg mL −1 insulin, 0.1 μg mL −1 hydrocortisone, and 0.1 μg mL ; R&D Systems, Oxford, UK)
individually or all three in combination. Opti-MEM® alone served as the control. Conditioned culture medium was collected after 4 and 6 days of culture. On day 6, explants were processed for analyses of placental viability, cell turnover, nutrient transport, endocrine section, and cytokine expression.
| Placental explant and maternal T-cell coculture
Villous tissue explants were prepared as above. 
| CD4 and CD8 T-cell isolation
| Cell migration
Explants that had been cocultured with maternal CD4 and CD8 T cells were fixed in 10% NBF, embedded in OCT, and frozen at −80°C.
10 μm sections were mounted with aqueous DAPI-containing mountant and viewed with a Zeiss fluorescence microscope (Zeiss, Welwyn
Garden City, UK) to determine the presence of labeled CD4 and CD8
T cells in the villous stroma.
| Assessment of system a amino acid transporter activity
Following the culture period, placental explants were incubated in buffer with the radiolabeled amino acid analogue N-methylated ami-
) as previously described. 15 The incubation buffer was either control Tyrode's or Na Hempstead, UK). The radioactivity of the explant lysate was determined using a β-scintillation counter. System A is a Na + -dependent nutrient transporter, and its activity was calculated by subtracting 14 CmeAIB uptake in Na + -free Tyrode's from uptake in control Tyrode's buffer, with adjustment for explant protein content. 
| hCG and PlGF hormone secretion
| Proliferation, apoptosis, STB regeneration, and leukocytes in explants
Proliferation and apoptosis were assessed in formalin-fixed explants using immunostaining and quantification of markers of proliferation (Ki67; Dako, Cambridge, UK) and apoptosis (M30; Roche, West Sussex, UK). STB regeneration was investigated by assessing area of immunostaining for cytokeratin 7 (CK7; Dako). The presence of leukocytes in explants was determined by immunostaining for the cell surface marker
CD45 (leukocyte common antigen [Dako]). A standardized laboratory
protocol for immunostaining with colorimetric detection was followed, as described previously. 10, 23 Primary antibodies were applied at the following concentrations: CK7 0.9 μg mL . Each tissue section had a corresponding negative control on which mouse IgG (Sigma-Aldrich, Dorset, UK) was applied at the same concentration as the primary antibody. 
| Image capture and analysis
| Statistical analysis
A power calculation using prior data on hCG secretion, system A activity, and cytokine production and secretion from culture in hypoxic conditions or with dexamethasone determined that four to six samples per group would be required with an 80% power, α=.05. 
| RESULTS
| An in vitro model of VUE shows altered placental function
Representative images of the coculture explants (n=6) illustrate CD4
and CD8 T cells in the intervillous space, the equivalent of the maternal blood space, and within the villous stroma ( Figure 1 ). Flow cytometry demonstrated that positive (CD8) and negative (CD4) antibody selection techniques yielded T-cell populations with ~91% and ~83% purity,
respectively. An average of ~12 000 cells (range 800-24 500) was ap- There was a significant decrease in hCG concentrations in conditioned culture medium at day 3 in the explants cultured with CD4/ CD8 T cells compared to those cultured in medium alone (P≤.01; Figure 3A ). A similar trend was detected for PlGF; however, in this group, there was a limited sample size (n=3; Figure 3B ). No significant differences were recorded in hCG concentrations at day 4. There was no significant difference in system A activity of the placental tissue or in proliferation, apoptosis, or STB regeneration/area in the explants cultured with CD4/CD8 T cells compared to control ( Figure 3D -F).
| Explant culture with VUE-associated cytokines alters placental function
There was a significant decrease in human chorionic gonadotropin (hCG) concentrations in conditioned culture medium at day 6 in the explants cultured with rhIL-2, rhIL-12, and IL-4 neutralizing antibody in combination compared to control (n=8, P<.05; Figure 4A ). There was a trend toward decreased placental growth factor (PlGF) in conditioned culture medium at day 3 in the explants cultured with all treatments, but this did not reach statistical significance (P=.16; Figure 1B ).
Treatment with individual cytokines did not affect hCG production.
Placental system A activity was not significantly affected by independent or combined rhIL-2, rhIL-12, and IL-4 neutralizing antibody treatment compared to control ( Figure 1C) . A significant reduction in proliferation (Ki67 staining) was detected in the explants treated with IL-2 (P<.05). No significant differences were seen in apoptosis or STB regeneration/area in any of the experimental conditions compared to control ( Figure 1D-F) . No significant differences were observed in cytokine levels in explant lysates or conditioned culture medium under any of the treatment conditions (Fig. S1 ).
| DISCUSSION
Villitis of unknown etiology is a well-documented inflammatory condition of the placenta in late pregnancy, and its association with poor pregnancy outcome (particularly FGR) is accepted. 6, 25, 26 Increased expression and/or secretion of IL-1β, IL-1RA, IL-6, IL-10, and IFN-γ were detected from explants cocultured with maternal T cells.
These data are consistent with our identification of IL-1 as a central mediator of inflammatory-induced placental dysfunction. 5 Women reporting a reduction in fetal movements (RFM) have a threefold increased risk of stillbirth or FGR; 33,34 the placentas from these pregnancies exhibit marked STB dysfunction, including reduced nutrient transport capacity, accompanied by altered trophoblast proliferation and apoptosis, and impaired endocrine function, including a reduction in hCG. 30 , 34 We recently identified elevated placental inflammation in these pregnancies, including increased expression of placental IL-1 family members, in the absence of infection. 5 In trophoblast, as in other cell types, IL-1 potently stimulates the expression of other pro-inflammatory cytokines,
for example IL-6 and CCL2, highlighting a coordinating role in mediating placental inflammation. [35] [36] [37] Furthermore, in vitro treatment with IL-1 impairs trophoblast fusion, viability, hCG secretion, and system A activity. 35 In the coculture model in the current study, elevated concentrations of IL-1Ra were detected in the culture medium; this supports that the elevated IL-1β produced is functional, as IL-1Ra expression is stimulated as a consequence of IL-1R activation. 5 These data therefore extend in vivo evidence of the contribution of placental inflammation to placental dysfunction and adverse pregnancy outcome.
Representative images of isolated T cells in coculture confirm that the cells were present in the intervillous space, and a proportion of T cells had migrated across the STB and infiltrated the placental villus.
Chronic intervillositis of unknown etiology (CIUE), another inflammatory infiltrate the placenta acting in a graft-vs-host manner. 40, 41 What remains to be elucidated is the manner of maternal-fetal cell interaction.
It is not yet known whether maternal T cells can be activated by fetal
Hofbauer cells or whether they recognize fetal MHC as non-self.
It is perhaps unsurprising that exogenous treatment with VUE- It should be noted that all of the placentas used in this study were from uncomplicated, healthy pregnancies in which it is likely that maternal tolerance of the feto-placental unit was well established. In addition, it was not possible to determine the Hofbauer cell population in the placentas prior to culture, a factor which may influence maternal T-cell interactions in VUE. 9 This may be a reason why experimental lesions were not as extensive as those seen in the high-grade villitis described in the literature. 4, 42 Other factors that may have influenced the extent of T-cell infiltration include the duration of the culture experiments compared to the duration of a pregnancy and the lack of blood flow in the in vitro model. The study was limited by the length of time the coculture could be sustained. A culture period of 4 days was chosen in order that the viability of the isolated T cells could be maintained. The cytokine culture experiments could be extended using a cytotrophoblast culture model rather than an explant culture model, although this would be more representative of the effect of generalized inflammation on trophoblast rather than VUE on the placenta.
If chronic disruption of the STB had occurred, then a change in nutrient transport capacity via system A may have been expected. The absence of a significant alteration in system A activity is potentially related to the relatively short exposure to cells/cytokines compared to that in utero. In this study, system A was chosen because of its pivotal role in supporting fetal growth; placental system A activity is reduced in FGR pregnancies compared to normal 43 and in pregnancy associated 
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